TICKERNOMICS Sign up
Last Update: 2024-03-28 02:14:24
Inotiv Inc. ( NOTV ) https://www.inotivco.com
10.03USD
Sector:
Healthcare
Industry:
Diagnostics & Research
Country:
United States
1y
3y
5y
10y
Historical Returns*:
SPY
31.15%
NOTV
130.57%
SPY
32.74%
-47.07%
NOTV
SPY
92.93%
NOTV
384.54%
SPY
224.41%
NOTV
300.86%
*Assumes dividends reinvested
Market Stats:
Market Capitalization($MM)
Enterprise Value($MM)
Daily Volume(MM)
257.91
615.25
0.59
Valuation Metrics:
Price/Earnings Ratio
Price/Sales Ratio
Price/Book Value
FCF Yield(%)
Dividend Yield(%)
EV/EBITDA
-8.92
0.44
1.01
-5.13
0.00
14.84
Profitability Stats:
Operating Margin %(ttm)
Gross Profit %(ttm)
EBITDA Margin %(ttm)
-6.92
22.13
7.08
Shareholder Value Creation:
Cost of Capital %(est)
ROIC %(ttm)
ROCE %(ttm)
Beta
16.4298
-2.02
-5.13
3.26
Other Earnings and Cash Flow Stats:
Inotiv Inc. ( NOTV ) Net Income TTM ($MM) is -110.11
Inotiv Inc. ( NOTV ) Operating Income TTM ($MM) is -26.38
Inotiv Inc. ( NOTV ) Owners' Earnings Annual ($MM) is 20.91
Inotiv Inc. ( NOTV ) Current Price to Owners' Earnings ratio is 12.37
Inotiv Inc. ( NOTV ) EBITDA TTM ($MM) is 26.11
Inotiv Inc. ( NOTV ) EBITDA Margin is 7.08%
Capital Allocation:
Inotiv Inc. ( NOTV ) has paid 0.00 dividends per share and bought back -0.18768 million shares in the past 12 months
Inotiv Inc. ( NOTV ) has reduced its debt by 9.6310000000001 million USD in the last 12 months
Capital Structure:
Inotiv Inc. ( NOTV ) Interest-bearing Debt ($MM) as of last quarter is 379
Inotiv Inc. ( NOTV ) Annual Working Capital Investments ($MM) are 68
Inotiv Inc. ( NOTV ) Book Value ($MM) as of last quarter is 254
Inotiv Inc. ( NOTV ) Debt/Capital as of last quarter is 149%
Other Balance Sheet Stats:
Inotiv Inc. ( NOTV ) has 22 million in cash on hand as of last quarter
Inotiv Inc. ( NOTV ) has 109 million of liabilities due within 12 months, and long term debt 379 as of last quarter
Inotiv Inc. ( NOTV ) has 25 common shares outstanding as of last quarter
Inotiv Inc. ( NOTV ) has 0 million USD of preferred stock value
Academic Scores:
Inotiv Inc. ( NOTV ) Altman Z-Score is 0.30 as of last quarter
Inotiv Inc. ( NOTV ) Piotroski Score is 5.00 as of last quarter
Corporate Governance:
Inotiv Inc. ( NOTV ) largest shareholder is owning shares at 0.00 ($MM) value
Michael Garrett(an insider) Bought 5000 shares of Inotiv Inc. ( NOTV ) for the amount of $14150.00 on 2023-12-14
18.83% of Inotiv Inc. ( NOTV ) is held by insiders, and 26.85% is held by institutions
Inotiv Inc. ( NOTV ) went public on 1997-11-25
Other Inotiv Inc. ( NOTV ) financial metrics:
FCF:-25.03
Unlevered Free Cash Flow:-29.14
EPS:-2.39
Operating Margin:-6.92
Gross Profit Margin:22.13
Div. Payout Ratio%:0.00
Div. Growth YoY%:0.00
Equity Return%:-24.22
Beta:3.26
Buffet's Owners Earnings:20.91
Price to Owner's Earnings:12.37
About Inotiv Inc. ( NOTV ) :
Inotiv, Inc. provides nonclinical and analytical drug discovery and development services to the pharmaceutical and medical device industries. It operates through two segment, Discovery and Safety Assessment (DSA), and Research Models and Services (RMS). The DMS segment manufactured scientific instruments for life sciences research and the related software for use by pharmaceutical companies, universities, government research centers, and medical research institutions under the Company's BASi product line. The RMS segment engages in commercial production and sales of research models, diets, bedding, and bioproducts. The company offers research and discovery services including, computational toxicology, disease pharmacology, DMPK, safety pharmacology, discovery bioanalysis, exploratory, surgical models and medical device, and cell and molecular biology; non-clinical safety assessment includes, general and genetic toxicology, regulated bioanalysis, biotherapeutics, and development and reproductive toxicology; pathology services, such as histology, digital, clinical, and medical device pathology; bioanalysis includes, nonregulated discovery bioanalysis, biotherapeutics, and regulated preclinical and clinical bioanalysis; proteomics; and consulting services. The company operates in the United States, rest of North America, the Pacific Rim, Europe, and internationally. The company was formerly known as Bioanalytical Systems, Inc. and changed its name to Inotiv, Inc. in March 2021. Inotiv, Inc. was incorporated in 1974 and is headquartered in West Lafayette, Indiana.
User Content from Tickernomics. Created by Luminus.
DISCLAIMER

This web site and its creators are not certified financial advisors. All opinions/suggestions expressed on this website should not be treated as specific inducement to make a particular investment or follow a particular strategy, but only as an expression of an opinion.The Company doesn't warrant the information provided on the website for its completeness or accuracy, and it should not be relied upon as such. The Company is not under any obligation to update or correct any information provided on this website.The content of this website is published in the United States of America and persons who access it agree to do so in accordance with applicable U.S. law.Past performance is not indicative of future results. The Company doesn't guarantee any specific outcome or profit. You should be aware of the real risk of loss in following any strategy or investment discussed on this website.Strategies or investments discussed may fluctuate in price or value. Investors may get back less than invested. Investments or strategies mentioned on this website may not be suitable for you. This material does not take into account your particular investment objectives,financial situation or needs and is not intended as recommendations appropriate for you. You must make an independent decision regarding investments or strategies mentioned on this website. Before acting on information on this website, you should consider whether it is suitable for your particular circumstances and strongly consider seeking advice from your own financial or investment adviser.